No Bail for Pharma Firm Owner Accused of Producing Spurious Drugs Farhat Nasim24 Dec 2024 6:03 PM ISTThe court noted that granting bail would encourage other drug manufacturers to produce and market spurious drugs for easy money.
NPPA Fixes Retail Price of 65 New Drugs, Ceiling Price of 20 Formulations, Details Farhat Nasim21 Dec 2024 3:02 PM ISTNew Delhi: Through recent notifications, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers,...
60% of Drug Inspector Posts Vacant at CDSCO, Parliamentary Panel Calls for Immediate Staffing Review Farhat Nasim19 Dec 2024 5:06 PM ISTNew Delhi: The Parliamentary Standing Committee on Chemicals and Fertilizers has raised concerns about the staffing situation at the Central Drugs...
Aurobindo Pharma Slapped With Rs 11 Crore GST Demand, Plans Appeal Farhat Nasim14 Dec 2024 6:36 PM ISTHyderabad: Aurobindo Pharma has been hit with a Rs 11 crore GST demand by Andhra Pradesh authorities, accusing the company of overstating its Input...
Indian Pharma Market Posts Robust 10.7% Growth in November, Foracort Tops Sales: IQVIA Farhat Nasim14 Dec 2024 5:52 PM ISTLeading the market, Foracort, a respiratory drug widely used for asthma, secured the top position among brands with sales of Rs 82 crore.
116 pharma firms face strict penalties over substandard drugs Farhat Nasim6 Dec 2024 4:05 PM ISTShimla: In a significant move aimed at maintaining drug quality standards, Himachal Pradesh's Drug Control Administration has taken strict action...
USFDA Inspection: Alembic Pharma gets form 483 with 5 procedural observations for Gujarat plant Farhat Nasim25 Nov 2024 3:47 PM ISTThe US Food and Drug Administration (USFDA) conducted inspection at Jarod-based solid oral formulation facility.
DCGI Warns Cosmetic Industry Against Overlapping Claims With Pharma Products Farhat Nasim23 Nov 2024 3:07 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has issued a stern warning to the cosmetics industry to adhere to strict regulatory...
Punjab: Tribunal Slaps Rs 5 Crore Interim Fine on Pharma Unit for Violations Farhat Nasim23 Nov 2024 1:27 PM ISTThe NGT bench also directed the PSPCB to initiate criminal proceedings against the pharma unit for past violations
Torrent Pharma Receives USFDA Clearance for Pithampur Facility with VAI Classification Farhat Nasim23 Nov 2024 12:49 PM ISTMumbai: Torrent Pharmaceuticals Limited has announced that the company received an Establishment Inspection Report (EIR) from the United States...
GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report Farhat Nasim22 Nov 2024 5:40 PM ISTNew Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...
Unexo Lifesciences Faces USFDA Heat Over Serious CGMP Violations Farhat Nasim22 Nov 2024 2:13 PM ISTIn response to the issues, the USFDA recommended a voluntary recall of all drug products manufactured at Unexo's facility for the U.S. market.
